Tamtam Try Tamtam free
PHOENIX group - Integrated Healthcare Provider logo

PHOENIX group - Integrated Healthcare Provider account plan

European pharmaceutical wholesale leader

At a glance

PHOENIX group is a Mannheim-based pharmaceutical wholesaler and pharmacy operator in 29 European markets, with EUR 53,113.8 million revenue in 2025/26.

PHOENIX group, based in Mannheim and owned solely by the Merckle family, runs pharmaceutical wholesale, pharmacy retail and services for the pharmaceutical industry in 29 European healthcare markets. It operates 204 logistics sites, is number 1 in pharmaceutical wholesale in 14 European countries and owns over 3,200 pharmacies in 16 countries, over 1,900 of them under the BENU brand. In fiscal 2025/26 (February 2025 to January 2026) revenue was EUR 53,113.8 million (+6.8%), profit before tax EUR 636.5 million (+36.7%) and profit after tax EUR 499.1 million, with 48,375 employees at 31 January 2026. The group is not listed but issues bonds and carries an S&P BB+ rating with a positive outlook.

Business units

Strategic priorities

WINGS strategic agenda
WINGS aims at profitable growth and a stronger market lead through three priorities: operational excellence, customer centricity and entrepreneurship, and digitalisation.
LEAN and the PHOENIX Production System
LEAN, launched in 2023, now runs in 23 countries across distribution centres, pharmacies and administration, with over 20,000 employees involved; IT & Digital and Healthcare Logistics started the roll-out in 2025/26.
Data and AI
A Data Hub centralises wholesale and retail transaction data from every country, and the PHOENIX AI Factory takes AI use cases to implementation in 20 countries, covering working capital, B2B customer service, invoice checks, tenders and dynamic pricing.
IT consolidation
Harmonising merchandise-management systems, integrating the former McKesson Europe units and modernising logistics and finance applications in several countries, plus a Digital Workplace Programme in 24 countries.
Own brands, loyalty and e-commerce
The private-label range grew by 264 SKUs to over 900 SKUs in 21 markets, and a Europe-wide loyalty programme started in Serbia in August 2025 is planned for Norway, Ireland and Slovakia in 2026/27.
Carbon neutrality by 2030
The group targets carbon neutrality in its own operations by 2030 and is preparing for CSRD reporting.

Latest results

Fiscal 2025/26 (to 31 January 2026) beat the guidance of a moderate profit increase: revenue rose 6.8% to EUR 53,113.8 million, EBITDA 11.2% to EUR 1,251.5 million and profit before tax 36.7% to EUR 636.5 million. Gross margin slipped from 10.00% to 9.85%. Operating cash flow rose to EUR 989.3 million and net debt fell 10.2% to EUR 2,646.7 million, with the equity ratio at 27.0%. For 2026/27 the board expects a slight increase in revenue, profit before tax and the equity ratio, with revenue growth slightly above the European pharma markets, expected to grow about 7.0% in 2026.

Investments and deals

Capex on pharmacies and distribution
Capital expenditure was EUR 260.8 million in 2025/26, mostly for the pharmacy network, modernising distribution centres, automation and logistics services for the pharmaceutical industry.
Acquisitions
ApoEx Privat Vård (Sweden, July 2025) and HAEMATO PHARM GmbH (Germany, year-end); EUR 78.9 million was spent on acquisitions, and buying pharmacies and wholesalers remains part of the strategy.
Győr distribution centre
A new distribution centre in Hungary, the largest construction project, expected to start operating at the end of 2026.
Refinancing
The syndicated facility was refinanced early in July 2025 and raised by EUR 250 million to EUR 1.5 billion; a EUR 500 million 4.875% bond is due 10 July 2029.

Challenges and risks

Margin pressure
Gross margin slipped from 10.00% to 9.85% on a higher cost-of-goods ratio, and wholesale earnings depend on terms with customers and suppliers in competitive markets.
Healthcare savings and online competition
Lower purchasing power, government healthcare savings measures and online competitors challenge the traditional pharmacy and wholesale business.
Energy and transport costs
Transport and energy make up about 13% of total costs, so high fuel and energy prices remain a risk.
IT outages, cyberattacks and site disruption
IT outages and cyberattacks are named risks, and the October 2025 fire that destroyed the Freiburg distribution centre forced other German centres to take over deliveries.
Supply shortages
Drug supply shortages were a challenge in the year; the group works with suppliers on out-of-stock transparency and holds additional safety stock.

What leadership says

“we have proven our resilience and defended our position as a leading healthcare provider in Europe”

Sven Seidel, CEO (Chairman of the Executive Board) · CEO letter, Annual Report 2025/26, May 2026 (translated from German)

“from e-prescriptions to digital customer services to data-driven logistics solutions”

Sven Seidel, CEO (Chairman of the Executive Board) · On digitalisation in every country, PHOENIXprint interview, autumn 2025 (translated from German)

“take advantage of growth opportunities in Europe wherever they arise”

Dr. Bernd Scheifele, Chairman of the Supervisory Board · Supervisory board report, Annual Report 2025/26 (translated from German)

Where a supplier can help

Automation and warehouse systems
Capex on modernising distribution centres and automation, plus the new Győr distribution centre, create openings for warehouse automation and logistics technology suppliers.
AI and data use cases
The AI Factory and Data Hub programmes, covering dynamic pricing, B2B customer service automation and invoice checks, fit vendors of AI, data and pricing tools.
ERP and IT harmonisation
Harmonising merchandise-management systems and integrating the former McKesson Europe units point to needs in system integration and migration services.
Energy and transport cost reduction
With transport and energy about 13% of total costs and a 2030 carbon neutrality target, fleet, routing and energy-efficiency suppliers have a direct case.
Cybersecurity and business continuity
Cyberattacks and IT outages are named risks and the Freiburg fire showed the cost of site disruption, which supports resilience and security offers.

Tamtam's reading of the priorities and challenges above, not the company's own words.

Selling to companies like PHOENIX group - Integrated Healthcare Provider?

Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.

Find similar companies

Key documents

Read in full by Tamtam; each summary links to the document itself.

Questions about PHOENIX group - Integrated Healthcare Provider

What does PHOENIX group do?

PHOENIX supplies pharmacies, doctors and medical institutions as a pharmaceutical wholesaler, runs over 3,200 own pharmacies in 16 countries (BENU, Apotek 1, Rowlands, McCabes, Help Net), and provides logistics and marketing services to the pharmaceutical industry in 29 European markets.

What is PHOENIX group's revenue?

Revenue was EUR 53,113.8 million in fiscal 2025/26 (February 2025 to January 2026), up 6.8%, with profit before tax of EUR 636.5 million.

How many employees does PHOENIX group have?

48,375 employees at 31 January 2026, the largest workforces being in the UK, Norway, the Netherlands and Germany.

Who leads PHOENIX group?

Sven Seidel chairs the Executive Board as CEO, and Dr. Bernd Scheifele chairs the Supervisory Board. The Merckle family is the sole owner.

What is PHOENIX group's strategy?

Its WINGS agenda focuses on operational excellence (LEAN), customer centricity with own brands and a loyalty programme, and digitalisation through the Data Hub and AI Factory, alongside acquisitions of pharmacies and wholesalers.

Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)